Table 1.
Characteristics of deceased patients.
| Patient 1 | Patient 2 | ||
|---|---|---|---|
| Demography | Country | Ecuador | Mexico |
| Sex, age | Female, 37 years | Male, 30 years | |
| Body Mass Index | 23.7 kg/m2 | 28.3 kg/m2 | |
| Ethnicity | Mestizo | Mestizo | |
| Pregnancy (present or past) | No | – | |
| Employment | Office clerk | Workman | |
| Number of cohabitants | None | 2 (no children, no COVID) | |
| Smoking, alcohol consumption, substance abuse | No | No | |
| Comorbidities | No | Hypertension | |
| MS history | Type of MS, disease duration | PPMS, 2 years | RRMS, 1 year |
| Last EDSS | 3.0 | 3.0 | |
| MS treatment | Rituximab | Ocrelizumab | |
| DMD interrupted, and reason | No | Yes (due to COVID–19 infection) | |
| Previous treatment | No | No | |
| Recent use of methylprednisolone | No | No | |
| WBC and lymphocyte results | Normal | Normal | |
| COVID, signs & symptoms | Signs and symptoms | Fatigue, chills, epigastric pain | Fever > 38, cough, fatigue, sputum production, sore throat |
| Presence of pneumonia | Yes | Yes | |
| Potential exposure to source of transmission | Family | Work | |
| COVID laboratory tests | Confirmed Covid | Confirmed Covid | |
| Therapies during hospitalization | Intravenous antibiotics, systemic glucocorticoids, oxygen therapy |
Intravenous antibiotics, systemic glucocorticoids, oxygen therapy |
|
| Hospitalization | Yes | Yes | |
| ICU | Invasive ventilation | Invasive ventilation | |
| Cause of death | COVID-related complications | COVID-related complications |